BIRC5 and cancer: We hypothesized that nanoradiosensitizers with desired surface characteristics could be used to deliver small interfering RNA (siRNA) cocktails targeting survivin, HIF‐1α, and TGF‐β to improve RT efficacy by increasing radiosensitivity of cancer cells.